Long-term ethanol consumption promotes hepatic tumorigenesis but impairs normal hepatocyte proliferation in rats
Journal of Nutrition, v. 141, n. 6, p. 1049-1055, 2011.
Chavez, Pollyanna R. G.
Paiva, Sergio Alberto Rupp de
Seitz, Helmut K.
Chronic and excessive alcohol consumption has been related to an increased risk of several cancers, including that of the liver; however, studies in animal models have yet to conclusively determine whether ethanol acts as a tumor promoter in hepatic tumorigenesis. We examined whether prolonged alcohol consumption could act as a hepatic tumor promoter after initiation by diethylnitrosamine (DEN) in a rat model. Male Sprague-Dawley rats were injected with 20 mg DEN/kg body weight 1 wk before introduction of either an ethanol liquid diet or an isoenergic control liquid diet. Hepatic pathological lesions, hepatocyte proliferation, apoptosis, PPARα and PPARγ, and plasma insulin-like growth factor 1 (IGF-1) levels were assessed after 6 and 10 mo. Mean body and liver weights, plasma IGF-1 concentration, hepatic expressions of proliferating cellular nuclear antigen and Ki-67, and cyclin D1 in ethanol-fed rats were all significantly lower after 10 mo of treatment compared with control rats. In addition, levels of hepatic PPARγ protein, not PPARα, were significantly higher in the ethanol-fed rats after prolonged treatment. Although ethanol feeding also resulted in significantly fewer altered hepatic foci, hepatocellular adenoma was detected in ethanol-fed rats at 10 mo, but not in control rats given the same dose of DEN. Together, these results indicate that chronic, excessive ethanol consumption impairs normal hepatocyte proliferation, which is associated with reduced IGF-1 levels, but promotes hepatic carcinogenesis. © 2011 American Society for Nutrition.
Showing items related by title, author, creator and subject.
The offspring from rats fed a fatty diet display impairments in the activation of liver peroxisome proliferator activated receptor alpha and features of fatty liver disease Heinecke, Maria Florencia; Mazzucco, María Belén; Fornes, Daiana; Roberti, Sabrina Lorena; Jawerbaum, Alicia Sandra; White, Verónica (Elsevier Ireland, 2020-07)Maternal obesity programs liver derangements similar to those of NAFLD. Our main goal was to evaluate whether these liver anomalies were related to aberrant PPARα function. Obesity was induced in female Albino-Wistar rats ...
Quercetin prevents liver carcinogenesis by inducing cell cycle arrest, decreasing cell proliferation and enhancing apoptosis Casella, María Laura; Parody, Juan Pablo; Ceballos Mancini, María Paula; Quiroga, Ariel Dario; Ronco, Maria Teresa; Frances, Daniel Eleazar Antonio; Monti, Juan Alberto; Pisani, Gerardo Bruno; Carnovale, Cristina Ester; Carrillo, Maria Cristina; Alvarez, Mar (Wiley, 2014-02)SCOPE: Quercetin is the most abundant flavonoid in human diet. It has special interest as it holds anticancerous properties. This study aims to clarify the mechanisms involved in quercetin effects during the occurrence ...
Galectin-1 controls the proliferation and migration of liver Sinusoidal endothelial cells and their interaction with hepatocarcinoma cells Manzi, Malena; Bacigalupo, Maria Lorena; Carabias, Pablo; Elola, Maria Teresa; Wolfenstein, Carlota Elisa; Rabinovich, Gabriel Adrián; Espelt, Maria Victoria; Troncoso, María Fernanda (Wiley, 2016-07)Galectin-1 (Gal1), a beta-galactoside-binding protein elevated in hepatocellular carcinoma (HCC), promotes epithelial-mesenchymal transition (EMT) and its expression correlates with HCC growth, invasiveness and metastasis. ...